| Literature DB >> 31882887 |
Ene Reimann1, Kristi Abram2,3, Sulev Kõks4,5, Külli Kingo2,3, Alireza Fazeli6,7.
Abstract
To evaluate skin tissue gene expression patterns correctly, extracting sufficient quantities of good quality RNA is essential. However, RNA extraction from skin tissue is challenging, as the hyaluronic acid-collagen matrix is extremely difficult to homogenize. Although there are multiple ways to extract RNA from skin, there are no comparative studies that identify the most critical steps, e.g. sample collection, storage and homogenization. We analysed the various steps involved in RNA extraction (i.e. biopsy collection as dry biopsy or into nucleotide stabilizing reagents, different storage conditions, enzymatic digestion, stator-rotor and bead motion-based homogenizing combined with column-based RNA purification). We hypothesised that domestic pig skin is applicable as a model for human skin studies. Altogether twenty different workflows were tested on pig skin and the four most promising workflows were tested on human skin samples. The optimal strategy for extracting human skin RNA was to collect, store and homogenize the sample in RLT lysis buffer from the RNeasy Fibrous Tissue Kit combined with beta-mercaptoethanol. Both stator-rotor and bead motion-based homogenizing were found to result in high quality and quantity of extracted RNA. Our results confirmed that domestic pig skin can be successfully used as a model for human skin RNA studies.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31882887 PMCID: PMC6934780 DOI: 10.1038/s41598-019-56579-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Description of different workflows (WF).
| Workflow name | Sample collection | Enzymatic digestion | Homogenizing buffer | Homogenizing instrument and tube | RNA extraction and DNase treatment |
|---|---|---|---|---|---|
| WF1_D | APTR | Yes | QIAzol | Fastprep: D | RNeasy Fibrous Tissue Mini kit + DNase I |
| WF1_S | APTR | Yes | QIAzol | Fastprep: S | |
| WF2_D | APTR | No | QIAzol | Fastprep: D | |
| WF2_S | APTR | No | QIAzol | Fastprep: S | |
| WF3_D* | QIAzol | No | QIAzol | Fastprep: D | |
| WF3_S | QIAzol | No | QIAzol | Fastprep: S | |
| WF4_D | APTR | Yes | BME + LB | Fastprep: D | |
| WF4_S | APTR | Yes | BME + LB | Fastprep: S | |
| WF5_D | Dry biopsy | Yes | BME + LB | Fastprep: D | |
| WF6_D | APTR | No | BME + LB | Fastprep: D | |
| WF6_S | APTR | No | BME + LB | Fastprep: S | |
| WF7_D* | BME + LB | No | BME + LB | Fastprep: D | |
| WF7_S | BME + LB | No | BME + LB | Fastprep: S | |
| WF8_D | Dry biopsy | No | BME + LB | Fastprep: D | |
| WF9_M | APTR | Yes | QIAzol | GentleMACS: M | |
| WF10_M | APTR | No | QIAzol | GentleMACS: M | |
| WF11_M* | QIAzol | No | QIAzol | GentleMACS: M | |
| WF12_M | APTR | Yes | BME + LB | GentleMACS: M | |
| WF13_M | APTR | No | BME + LB | GentleMACS: M | |
| WF14_M* | BME + LB | No | BME + LB | GentleMACS: M |
QIAzol - QIAzol Lysis reagent, APTR - Allprotect Tissue Reagent, BME + LB - RTL lysis buffer from RNeasy Fibrous Tissue Mini kit containing beta-mercaptoethanol, Fastprep D/S - Fastprep-24 instrument with lysing matrix D or S tubes, GentleMACS M - GentleMACS Dissociator with M tubes. The D, S or M in WF name refer to the homogenizing tube (Fastprep lysing matrix D or S tubes or GentleMACS M tubes, respectively) applied in this WF.
*These workflows were used for validation with human samples.
Figure 1RNA quality and quantity values received by applying different workflows ordered according to the RIN values (starting from the workflow with highest RIN value). The RIN values are represented on top of the columns together with ±SD in brackets. The error bars represent the ±SD. (A) Pig skin samples; (B) Human skin sample.
Figure 2RNA quality values from human skin derived RNA samples. (A) RNA Integrity Numbers (RIN) obtained by applying the Agilent 2100 Bioanalyzer and RNA 6000 Nano kit. (B) The RNA absorbance spectrum measured with NanoDrop spectrophotometer.